This is a randomized, double-blind, placebo-controlled study of the investigational drug
uridine as a treatment for depressed adolescents with bipolar disorder (i.e. "bipolar
depression"). Participants initially randomized to placebo who complete the 6-week protocol
will be offered 6 months of open-label uridine treatment and follow-up. Participants
initially randomized to uridine will be offered the open-label treatment as well.
Phase:
N/A
Details
Lead Sponsor:
University of Utah
Collaborator:
The Depressive and Bipolar Disorder Alternative Treatment Foundation